CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced its planned presentations at ...
Living Heart Valve Bioreactor - 2023-2024 Capstone SDG Impact Award Winner (Tier 1): This project explored a new approach to heart valve replacements, helping researchers develop long-lasting ...
Living Heart Valve Bioreactor - 2023-2024 Capstone SDG Impact Award Winner (Tier 1): This project explored a new approach to heart valve replacements, helping researchers develop long-lasting ...
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing. Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced ...
The first poster entitled, “Biocatalytic production of MDMA and other phenylpropylamine derivatives,” presented an alternative process for MDMA production integrating yeast-based bioconversion and ...
Upon abstract acceptance, all posters must be uploaded and recorded on VoiceThread by January 26, 2026 at 5 p.m. All posters that are narrated on VoiceThread by the deadline will be officially listed ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results